Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.16 USD
Change Today +0.0199 / 14.21%
Volume 3.1K
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

immudyne inc (IMMD) Snapshot

Open
$0.10
Previous Close
$0.14
Day High
$0.16
Day Low
$0.10
52 Week High
04/21/14 - $0.24
52 Week Low
10/8/14 - $0.05
Market Cap
4.7M
Average Volume 10 Days
2.9K
EPS TTM
--
Shares Outstanding
29.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUDYNE INC (IMMD)

Related News

No related news articles were found.

immudyne inc (IMMD) Related Businessweek News

No Related Businessweek News Found

immudyne inc (IMMD) Details

Immudyne, Inc. develops, manufactures, and sells natural immune support products primarily in the United States. It offers nutraceutical and cosmetic product lines that consist of yeast beta glucans in oral and topical applications. The company‘s nutraceutical and cosmetic products for yeast beta glucans are the iNR line of once-daily oral capsules; and NAYAD and SGM line of Skin Care Essentials rejuvenating serums and creams. Immudyne, Inc. sells its products directly to consumers; and to pharmaceutical, nutraceutical, and consumer product companies through healthcare professionals and distributors. The company was incorporated in 1987 and is based in Mount Kisco, New York.

3 Employees
Last Reported Date: 03/30/15
Founded in 1987

immudyne inc (IMMD) Top Compensated Officers

Chief Executive Officer, President, Principal...
Total Annual Compensation: $145.6K
Compensation as of Fiscal Year 2013.

immudyne inc (IMMD) Key Developments

ImmuDyne, Inc. Announces Revenue Results for the First Quarter of Fiscal 2015

ImmuDyne, Inc. announced revenue results for the first quarter of fiscal 2015. The company announced first quarter revenues rose more than 50%, year over year, to approximately $288,000.

IPA Endorses ImmuDyne Line of Immune Support Supplements

ImmuDyne, Inc. announced that the Independent Pharmacy Alliance will endorse ImmuDyne's full line of Immune Support Products. During the educational process to over 600 IPA members provided by many PhD nutritional experts, discovered ImmuDyne and how its preventative impact affected. This product can be highly recommend for all members, their families and their patients. Because of my experience, IPA has contracted with ImmuDyne at very special and affordable pricing.

ImmuDyne, Inc. Hires Todd Goldman as Senior Vice President of Marketing and Sales

ImmuDyne, Inc. announced the hiring of Todd Goldman as Senior Vice President of Marketing and Sales.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMMD:US $0.16 USD +0.0199

IMMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMMD.
View Industry Companies
 

Industry Analysis

IMMD

Industry Average

Valuation IMMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUDYNE INC, please visit www.immudyne.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.